EMBRACE STEMI | Clinical Trial - EMBRACE STEMI

Description:

The goal of this phase 2 trial was to assess the safety and efficacy of bendavia, a novel agent that targets mitochondrial dysfunction.

Contribution to the Literature: The EMBRACE STEMI study suggests that bendavia does not affect infarct size in patients with anterior STEMI due to proximal/mid occlusion of the LAD compared with placebo.